Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
11/2008
11/13/2008US20080279906 Intracellular delivery of endothelial growth factor
11/13/2008US20080279882 Phyto-nutraceutical synergistic composition for hyperlipedemic condition
11/13/2008US20080279869 Method for reducing neuronal degeneration by administering cns-derived peptides or activated t cells
11/13/2008US20080279864 High Throughput Screen Utilizing Newly Discovered Intramolecular Neuronal Calcium Channel Interactions To Discover New Analgesics
11/13/2008US20080279857 Therapeutic Agent
11/13/2008US20080279856 Using heparin-binding protein specific monoclonal antibody to decrease nonapeptide separation; prevention and treatment of inflammation
11/13/2008US20080279841 Novel Therapeutic Molecular Variants And Uses Thereof
11/13/2008US20080279835 Using human umbilical cord progenitor cells to propagate myocardial tissues to treat coronary disease; tissue engineering and repair; regenerative medicine
11/13/2008DE19830732B4 Zusammensetzung, enthaltend mindestens einen die Blutfettwerte beeinflussenden Wirkstoff und seine Verwendung A composition comprising at least one lipid levels influencing drug and its use
11/13/2008DE102007021862A1 Wässrige pharmazeutische Zubereitung Aqueous pharmaceutical preparation
11/13/2008CA2689608A1 Use of citrulline for the treatment of conditions linked to an increase in protein carbonylation
11/13/2008CA2688317A1 Use of tp modulators for the treatment of cardiovascular disorders in aspirin sensitive and other populations
11/13/2008CA2686736A1 Methods and compositions for treating pulmonary hypertension
11/13/2008CA2686707A1 Pyrrolopyrimidin-7-one derivatives and their use as pharmaceuticals
11/13/2008CA2686457A1 Novel polymorphic forms
11/13/2008CA2686396A1 Controlled release oral formulations of ion channel modulating compounds and related methods for preventing arrhythmia
11/13/2008CA2685216A1 Thienopyridine and thiazolopyridine derivatives that inhibit prolyl hydroxylase activity
11/13/2008CA2684722A1 Combination therapy with a compound acting as a platelet adp receptor inhibitor
11/13/2008CA2684703A1 Bicyclic compound and pharmaceutical use thereof
11/13/2008CA2683760A1 Use of bipolar trans carotenoids as a pretreatment and in the treatment of peripheral vascular disease
11/12/2008EP1990343A2 Azaindoles
11/12/2008EP1990341A1 Triazolyl tropane derivatives as CCR5 modulators
11/12/2008EP1990053A1 Pharmaceutical composition for enhancing adiponectin production
11/12/2008EP1990052A1 Pharmaceutical package
11/12/2008EP1990049A2 Combination therapy of beta-blockers and non-steroidal anti-inflammatory drugs (NSAID)
11/12/2008EP1988916A1 Methods and agents for reducing oxidative stress
11/12/2008EP1988892A2 Modulators of muscarinic receptors
11/12/2008EP1988885A2 Combination of organic compounds
11/12/2008EP1628977B1 ANTIBIOTIC TETRAHYDRO-b-CARBOLINE DERIVATIVES
11/12/2008EP1549159B1 Beverages containing plant sterols
11/12/2008EP1523488B1 Novel thiophenylglycoside derivatives, methods for production thereof, medicaments comprising said compounds and use thereof
11/12/2008EP1478659B1 Biologically active peptides
11/12/2008EP1365771B9 Method of treating certain eye diseases
11/12/2008EP1343503B1 Heteroaryl urea neuropeptide y y5 receptor antagonists
11/12/2008CN201147507Y Long-acting blood pressure-reducing sustained-release degradation stick
11/12/2008CN101305017A Bioactive peptides identified in enzymatic hydrolyzates of milk caseins and method of obtaining same
11/12/2008CN101305007A Pyrazolo[4,3-d]pyrimidin-5-yl)derivative used as PDE5 inhibitors
11/12/2008CN101305000A 5-oxo-5,8-dihydro-pyrido-pyrimidines as inhibitors of C-FMS kinase
11/12/2008CN101304993A Compounds and compositions as ppar modulators
11/12/2008CN101304984A Oxazole and thiazole ppar modulator
11/12/2008CN101304970A Amorphous form of 1,2-dihydropyridine compound
11/12/2008CN101302515A Human antibodies that bind human TNF(alpha)
11/12/2008CN101302246A Melanin cortical hormone receptor heptapeptide excitant, preparation and use thereof
11/12/2008CN101302245A Melanin cortical hormone receptor tetrapeptide excitant, preparation and use thereof
11/12/2008CN101302221A Anti-platelet activating factor compound
11/12/2008CN101302204A Quinazolone compound, composition and application including the same
11/12/2008CN101301477A Isoquercitrin clathrate and preparation thereof
11/12/2008CN101301475A Peg化因子vii糖型 Peg factor vii sugar type
11/12/2008CN101301459A Medicated pillow
11/12/2008CN101301458A Medicament for treating chronic cardiac failure and preparation thereof
11/12/2008CN101301454A Navel plaster with powder for soothing heart
11/12/2008CN101301453A Chinese patent medicine powder for treating hematopathy
11/12/2008CN101301432A Chinese medicinal composition for treating cerebral hemorrhage
11/12/2008CN101301425A Formulation for treating diabetes and promoting coronary circulation and quality control method
11/12/2008CN101301423A Medicament for treating comprehensive hemorrhoid and preparation thereof
11/12/2008CN101301420A Medicament for treating angina pectoris of coronary heart disease
11/12/2008CN101301413A Cordyceps sinensis and Rhodiola rosea capsules and preparation thereof
11/12/2008CN101301411A Chinese medicinal composition for treating angina pectoris
11/12/2008CN101301407A Medicament for treating arthritis and angiitis
11/12/2008CN101301398A Chinese medicine for treating hypertension
11/12/2008CN101301384A Chinese medicinal composition for treating arteriosclerosis
11/12/2008CN101301381A Medicament for treating hypertension
11/12/2008CN101301377A Capsules of compound haw thorn leaf extract
11/12/2008CN101301376A Crataegutt oral freeze-dried tablet and preparation thereof
11/12/2008CN101301370A Method for preparing monoester type alkaloids using Chinese medicinal material of aconitum as raw material
11/12/2008CN101301353A Preparation of Dandengtongnao medicinal formulation and quality control method
11/12/2008CN101301351A Capsules for treating cardiovascular and cerebrovascular diseases and method for preparing the same
11/12/2008CN101301319A Preparation of granada flower polyphenol and uses thereof
11/12/2008CN101301318A Ginkgo leaf extract oral freeze-dried slices and preparation thereof
11/12/2008CN101301311A Potassium magnessium aspartape sterilized powder injection and preparation thereof
11/12/2008CN101301306A Use of DFT in preparing medicament for treating and preventing shock
11/12/2008CN101301304A Chinese medicinal composition for treating ischemic stroke and preparation thereof
11/12/2008CN101301286A Novel use of brasilein
11/12/2008CN101301267A Bilobalide B injection and preparation thereof
11/12/2008CN101301157A Chrysanthemum health care pillow
11/12/2008CN101301062A Health flavouring material edible for patients with elevated blood pressure
11/12/2008CN100432232C Method for extracting polyose from Hojothuria leucospilota, said polyose and its medicine use
11/12/2008CN100432070C Novel sulfamides and their use as endothelin receptor antagonists
11/12/2008CN100432062C Terphenyl derivatives, preparation thereof, compositions containing same
11/12/2008CN100432057C Crystalline form gamma-d of the chlorohydrate of ivabradine, process for its preparation and pharmaceutical compositions containing it
11/12/2008CN100432055C Tricyclic protein kinase inhibitors
11/12/2008CN100432049C Cycloalkene derivatives, process for producing the same and use
11/12/2008CN100431611C Compound of polypeptide-liposome and human vascular endothelial growth factor gene recombination plasmid and its use
11/12/2008CN100431604C C1 inhibitor with short half-life for transient treatment
11/12/2008CN100431579C Medicine for treating phlebothrombosis and thrombotic superficial phlebitis of lower limb and its prepn
11/12/2008CN100431575C Medicine composition for treating cardiac and cerebral vascular diseases
11/12/2008CN100431565C Mongolia medicine for treating coronary heart disease and angina pectoris
11/12/2008CN100431562C Chinese traditional medicinal preparation containing red sange root and safflower for treating cardiovascular and cerebrovascular diseases and preparing process thereof
11/12/2008CN100431560C Alcohol in use for reducing blood fat and lowering the blood pressure
11/12/2008CN100431537C Blood fluidity improving agent
11/12/2008CN100431534C Methods of inhibiting vascular permeability and apoptosis
11/12/2008CN100431532C Breviscapine and borneol constituted composite injection formulation and preparation method thereof
11/12/2008CN100431529C Soft capsule for reducing blood fat and its preparing method
11/11/2008US7449581 6-Substituted pyrido-pyrimidines
11/11/2008US7449495 e.g. 4-(3-(1-Adamantyl)-4-tert-butyldimethyl-silyloxyphenyl)benzaldehyde; antitumor, antiinflammatory agent; arthritic pathology, metastatisation, diabetic retinopathy, psoriasis, chronic inflammatory disease, and atherosclerosis; sarcoma, carcinoma, carcinoid, leukaemia
11/11/2008US7449493 N-[2-[[1-[[[(2,4-dimethylphenyl)methyl]amino]methyl]cyclohexyl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide; monocyte chemoattractant proteins receptor antagonists or partial agonists/antagonists; antiinflammatory agent, autoimmune diseases; rheumatoid arthritis, multiple sclerosis, atherosclerosis
11/11/2008US7449492 Therapeutic agents—I
11/11/2008US7449490 Pharmaceutically active compounds and methods of use
11/11/2008US7449484 angiogenesis inhibitor; Tie2 receptor kinase inhibitors; 2-tert-Butyl-4-naphthalen-2-yl-5-pyridin-4-yl-imidazole;2-tert-Butyl-4-(6-Ethoxynaphthalen-2-yl)-5-pyridin-4-yl-imidazole;4-(2-tert-Butyl-5-(6-methoxy-naphthalen-2-yl)-3H-imidazol-4-yl)-pyridine; etc.
11/11/2008US7449483 e.g. 2-(Ethyl-{4-[2-methyl-3-(4-trifluoromethyl-phenyl)-benzo[b]thiophen-6-yl]-butyl}-amino)-ethanol; 2,3-oxidosqualene-lanosterol cyclase inhibitor; antidiabetic, antitumor, antiproliferative agent; hypercholesterolemia, hyperlipemia, arteriosclerosis, vascular diseases, mycoses, gallstones